| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 23, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,340 | -- | 17,961 |
| Feb 26, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 211 | $87.10 | 17,750 |
| Feb 26, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 325 | $87.10 | 17,425 |
| Feb 27, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 186 | $92.19 | 17,239 |
| Feb 27, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 310 | $92.19 | 16,929 |
| Feb 28, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 188 | $91.02 | 16,741 |
| Feb 28, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 314 | $91.02 | 16,427 |
| Jun 06, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 4,802 | $55.49 | 15,622 |
| Feb 23, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 5,396 | -- | 13,202 |
| Feb 23, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 247 | $55.58 | 12,955 |
| Feb 23, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 94 | $55.58 | 12,861 |
| Feb 24, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 250 | $53.83 | 12,611 |
| Feb 27, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 401 | $57.25 | 12,210 |
| Feb 27, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 240 | $54.03 | 11,970 |
| Feb 24, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,172 | -- | 11,970 |
| Feb 28, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 247 | $53.32 | 11,723 |
| Feb 25, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 406 | $54.15 | 11,564 |
| Jul 05, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 406 | $45.93 | 11,158 |
| Mar 01, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 903 | $55.52 | 10,820 |
| Feb 24, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 4,171 | -- | 10,798 |
| Feb 23, 2024 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 1,913 | -- | 10,621 |
| Jun 06, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 5,127 | $70.46 | 10,495 |
| Jul 31, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 983 | $63.16 | 10,074 |
| Dec 23, 2022 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 2,000 | $51.45 | 9,158 |
| Jul 31, 2023 |
SVP, Outcomes
|
SVP, Outcomes | Form 4 | Open market or private sale of non-derivative or derivative security | 983 | $78.00 | 9,091 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.
For recent transactions, including derivative transactions, see our Section 16 SEC filings page.